Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 Events – – First Patient Dosed in Phase 2 Trial of SLS009 ...
MetaOptics Ltd (Catalist: 9MT) (“MetaOptics” or the “Company”, and together with its subsidiaries, the “Group”) recently ...
Vietnam Investment Review on MSN
MetaOptics advances growth strategy and leadership transition
SINGAPORE, March 20, 2026 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group") recently announced a series of strategic ...
Tata Consultancy Services, a global leader in IT services, consulting, and business solutions, and Swissport International Limited, a global leader in aviation services, have extended and expanded ...
Mahindra Holidays & Resorts India Limited, India's leading leisure hospitality company, today announced the launch of two new resorts in Club Mahindra Amba Ghat, Maharashtra and Club Mahindra ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results